Sol-Gel Technologies (SLGL) Accumulated Expenses (2016 - 2018)
Sol-Gel Technologies' (SLGL) quarterly Accumulated Expenses came in at $1.0 million in Q4 2018, up 13.3% year-on-year from $910000.0 in Q4 2017, and down 29.77% on a QoQ basis from $1.5 million in Q3 2018.
Sol-Gel Technologies (SLGL) Accumulated Expenses (2016 - 2018) Analysis & Trends
Sol-Gel Technologies (SLGL) has 3 years of Accumulated Expenses data on file, last reported at $1.0 million in Q4 2018.
- On a quarterly basis, Accumulated Expenses rose 13.3% year-over-year to $1.0 million in Q4 2018; TTM through Dec 2018 was $1.0 million, a 13.3% increase from a year earlier, with the FY2018 full-year figure at $1.0 million, up 13.3% from the prior year.
- Accumulated Expenses for Q4 2018 stood at $1.0 million, down from $1.5 million in the prior quarter.
- Over the last five years, Accumulated Expenses for SLGL reached as high as $3.6 million in Q4 2016 and fell as low as $910000.0 in Q4 2017.
- Historically, Accumulated Expenses has averaged $1.7 million across 3 years, with a median of $1.5 million in 2018.
- Across the five-year window, Accumulated Expenses sank 74.88% in 2017 and increased 13.3% in 2018, its largest moves.
- Year by year, Accumulated Expenses stood at $3.6 million in 2016, then slumped by 74.88% to $910000.0 in 2017, then gained by 13.3% to $1.0 million in 2018.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $1.0 million in Q4 2018, $1.5 million in Q3 2018, and $1.5 million in Q1 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.03 Mn |
| Sep 30, 2018 | 1.47 Mn |
| Mar 31, 2018 | 1.53 Mn |
| Dec 31, 2017 | 910,000.00 |
| Dec 31, 2016 | 3.62 Mn |